Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. (603707.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 7.48

From 52W high−33.56%

Volume5.97M

Market capCNY 12.57B

P/E (TTM)21.6x

P/S (TTM)3.0x

Div yield1.34%

Key dataSep 18, 2026

Open

CNY 7.48

From 52W high

−33.56%

Volume

5.97M

Market cap

CNY 12.57B

ValuationView details →

P/E (Fwd)

17.0x

EV/EBITDA

12.3x

P/E (TTM)

21.6x

RSI (14)

41.2

MomentumView details →

1D Return

−2.26%

YTD Return

−17.39%

ValuationView details →

P/E (Fwd)

17.0x

P/E (TTM)

21.6x

EV/EBITDA

12.3x

EV/Sales

2.9x

P/S (TTM)

3.0x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

38.87%

Net Margin

14.52%

EBITDA Margin

23.40%

ROE (TTM)

8.38%

ROA (TTM)

5.48%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+6.03%

EPS YoY

−17.45%

FCF YoY

+42.64%

Revenue CAGR 3Y

+2.44%

EPS CAGR 3Y

−18.70%

EBITDA YoY

—

MomentumView details →

1D Return

−2.26%

YTD Return

−17.39%

1Y Return

−30.73%

RSI (14)

41.2

vs 50D SMA

−5.85%

vs 200D SMA

−14.98%

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

2.27x

Quick Ratio

1.40x

Div Yield

1.34%

Div Rate

CNY 0.10

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.06

EPS Surprise

−58.89%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.08

Avg Surprise (4Q)

−58.89%

Rev Surprise

−1.06%

Financials snapshotView financials →

Revenue (TTM)

4.03B

Net Income (TTM)

585.83M

Op. CF (TTM)

1.53B

Next earningsOct 26, 2026 →

Latest newsMore news →

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. received a drug registration certificate from the National Medical Products Administration for its propofol emulsion injection 20ml:200mg, marking the approval for marketing in China.76d ago

Similar companies

浙江医药600216.SH 国邦医药605507.SH Sunshine Lake Pharma Co., Ltd.06887.HK Ab&B Bio Tech Co Ltd.02627.HK 微芯生物688321.SH 九洲药业603456.SH Find similar companies →

Latest newsMore news →

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. received a drug registration certificate from the National Medical Products Administration for its propofol emulsion injection 20ml:200mg, marking the approval for marketing in China.76d ago